DNA2.0

Here we develop relevant new molecular and immunological tools and approaches for improving human and veterinary precision medicine and molecular pharmacology. We are supporting R&D projects of clients and in collaborations with our best knowledge and engagement as well as internal R&D projects. We are using the generation of high performance synthetic and artificial bio-molecules for specific requirements of analytical purposes like the development of cell based assays with expressed bio-molecules as well as improving production strains. As geneticists we are capable for survailling publicly announced research and development projects. We are controlling if inquired gene syntheses fit into the announced concepts of prjects or not. Synthetic Biology is the key technology for development of sustainability on all levels of life. Last but not least generally are bio-production processes with microorganisms in all its facets and bio-recycling of waste most important options for the future. ATG (= Advanced Technical Genetics & Genomics) was founded more than 20 years ago in 2001 based on a granted patent for gene synthesis.

Optimized by machine learning and bioinformatics, powered by vendors you trust. Design long, short, or complicated genes: place one order to rule them all. Set codon optimization, design constraints, budget requirements, and deadlines—we will satisfy them. Don’t let a synthesis delay stall your project.

We provide an end-to-end platform for genetic design by integrating state-of-the-art synthetic biology with computational tools. Using our platform, we develop a commercial-grade cell line specifically for your program and ship it to you. We provide you with vials of clonal cell banks, transfer the process to your site, and provide documentation for your regulatory filing. Engineered, highly characterized GMP host cells for therapeutics production with supporting regulatory documentation. We perform cell line development and upstream process development at our site using state-of-the-art equipment and industry-leading timelines. We integrate multiple technologies at the leading edge of synthetic biology, acting as your one-stop shop for cells, genetic tools, computational models, and more. We continuously improve our biological tools, data-driven models, and processes in our state-of-the-art lab in Boston.

Molgenium is dedicated to enhancing the treatment of rare and incurable genetic diseases through the development of cell and gene therapies derived from a patient's own cells. Our mission is to address fetal diseases without compromising quality of life, and we remain steadfast in our commitment to this goal. At our organization, we are committed to advancing the field of personalized medicine by expanding access to cell and gene therapies, as well as human tissues, for patients around the world. Our goal is to help patients worldwide by providing access to cutting-edge therapies that are tailored to their specific needs. Molgenium is a trusted leader in the field of ATMP development and production, supported by a team of expert scientists and CMC professionals with a proven track record of success. We provide comprehensive end-to-end support, guiding you through the entire development process from initial stages to regulatory approval, clinical exemption, and market launch. Choose Molgenium and achieve your ATMP development goals with confidence. Second, Molgenium aims to comprehensively cover the entire product development process, providing support at every stage of the journey.

And we are enjoying a long track record of successful antibodies as attested by the numerous published literature citations every year. Our team of chemists can look back on many years of experience in the successful synthesis of numerous biologically active peptides, including :. Our established immunisation protocols & procedures have enabled us to deliver our customers with optimal, consistent quality antibodies for many years. Genosphere Biotechnologies offers this unique guarantee to our customers for anti-peptide antibodies as well as for anti-protein antibodies services, provided sample requirements are fulfilled. We offer a complete range of genetic engineering services, from codon optimization, to subcloning, site-directed mutagenesis and large scale plasmid preparations. Genosphere Biotechnologies is your reliable, affordable quality services provider. Founded in 1997, Genosphere Biotechnologies now enjoys thousands of literature Materials & Methods citations worldwide and contributes to numerous original Research & Development projects across all areas of life sciences. Sequence Design: To address issues related to codon usage bias, we offer codon optimization services, improving protein expression.

GeneMedi Vision : Curiosity & Creativity to Improve Human Health. We develop solutions for the therapeutics and diagnostics industry. GTU empowers self-capabilities for application development to develop more powerful products and solutions to meet the needs of the biologics industry. GTU & G-NEXT combine the novel AAV rational design, smart discovery and State-of-the-Art manufacturing to meet the industrial unmet for next generation of gene therapy. Membrane Protein & antibodies artificail design, discovery and State-of-the-Art Manufacturing. High quality, scalable, State-of-the-Art Manufacturing in gene therapy vectors including adenoassociated virus (AAV) vector, lentivirus vector and adenovirus vector.